What is NeuroResponse?
I’ve had four or five urine tests done through NeuroResponse. They would all have involved a trip to the GP surgery, dropping off the sample, having a call with the GP. I would have gone to the GP each of those times, so it’s averted those each of those times. NeuroResponse user
Take a look at our video which tells you more about the NeuroResponse journey. We have started in a few areas and hope to work with the NHS to scale across the UK. To find out more about whether we are in your area yet or if you are eligible to access NeuroResponse, please click here.
Why was NeuroResponse developed?
NeuroResponse
aims to:
Provide access to expert advice day and night.
Shorten waiting time for assessment of new MS symptoms.
Make urinary infection analysis and treatment faster and easier.
Create a secure system to share information.
What does NeuroResponse provide for people with MS?
NeuroResponse offers:
Personalised electronic care (E-care) plan and 24/7 access to specialist advice.
Resources to support symptom management including home testing kits and lab courier service to speed up diagnosis and treatment.
Secure data: With your consent all your information is stored safely in one place and will only be shared by people involved in your care.
NeuroResponse has been designed to enable:
Earlier detection and reduced
time to treat
Appropriate antibiotic use
Reduction in unplanned admissions resulting in more time at home
What are the benefits of signing up to NeuroResponse?
I think it’s really important that people with MS are able to have access to medical advice about specific symptoms and episodes on a timely basis. Now maybe NeuroResponse is well placed to provide this because you can phone up and ask about it. Person with MS
The same study showed how NeuroResponse provides the following benefits:
- Reducing the use of GP and emergency hospital services for people with MS
- Reduced demand on other services
- Enabled fewer and shorter hospital admissions
- Reduced demand on GPs
Who can access NeuroResponse?
New NeUro App Pathway
What is the NeUro App Pathway?
In April 2023 we launched NeUro App as a pilot to a selected group of people across North Central London who have MS, Dementia and Parkinsons Disease. We work with NHS and other health charities and companies to deliver this programme. We also have several advisory boards that advise on science, ethics, diversity and inclusion.
Following the successful pilot, the NeUro App will be live across North Central London for this select group of people to use when they have a suspected urine infection.
Who has reviewed and approved NeUro App programme?
The NeUro App has been reviewed and approved by NHSE and SBRI panels. The service is compliant with the NHS Digital Technology Assessment Criteria (DTAC), the NHS Data Security and Protection Toolkit, registered with MHRA as a Class 1 Medical Device, and complies with the necessary safety, privacy and accessibility guidelines and policies.
What about our funding?
What will happen to the findings from the programme?
Discoveries made from the NeUro App programme will be shared with stakeholders and where appropriate published in scientific papers and made available online. Identities or any personal details will be kept confidential.
References:
1. NeuroResponse data on file. 2014.
2. Data sourced from Vantage, by Health iQ. Secondary care data is taken from the English Hospital Episodes Statistics (HES) database produced by the Health and Social Care Information Centre (NHS Digital, https://content.digital.nhs.uk/hes). Copyright 2017. See https://www.healthiq.co.uk/information-governance for further information.